Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer

Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer

Abstract Purpose Chemoradiotherapy (CRT) for rectal cancer is limited by its harmful side effects and its insufficient benefit on lateral lymph node metastases. The purpose of this study was to evaluate the long-term outcomes of S-1 and oxaliplatin with total mesorectal excision (TME) and lateral ly...

Full description

Bibliographic Details
Main Authors: Hajime Morohashi, Yoshiyuki Sakamoto, Takuya Miura, Takuji Kagiya, Kentaro Sato, Shinji Tsutsumi, Seiji Takahashi, Yoshihito Nakayama, Hiroaki Tamba, Shuntaro Matsumoto, Daiki Kasai, Kenichi Hakamada
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Gastroenterology
Subjects:
Rectal cancer
Lateral lymph node dissection
Neoadjuvant chemotherapy
S-1 and Oxaliplatin (SOX)
Online Access:https://doi.org/10.1186/s12876-024-03549-5

Internet

https://doi.org/10.1186/s12876-024-03549-5

Similar Items